Tiziana Life Sciences (TLSA) Other Non-Current Liabilities (2019 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Other Non-Current Liabilities of $9000.0 for Q2 2025, up 12.5% year-over-year from $8000.0 in Q2 2024, and down 25.0% quarter-over-quarter from $12000.0 in Q4 2024.
Tiziana Life Sciences (TLSA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Tiziana Life Sciences' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $9000.0 for Q2 2025.
- In Q2 2025, Other Non-Current Liabilities rose 12.5% year-over-year to $9000.0; the TTM figure through Jun 2025 stood at $9000.0 (up 12.5% YoY), while the FY2024 annual figure was $12000.0, down 14.29% from the prior year.
- Other Non-Current Liabilities for Q2 2025 stood at $9000.0, down from $12000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $365000.0 in Q4 2022, with the low at $6000.0 in Q2 2023.
- The 5-year median for Other Non-Current Liabilities is $10000.0 (2021), against an average of $57222.2.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities surged 3550.0% in 2022, then sank 96.16% in 2023.
- Tiziana Life Sciences' Other Non-Current Liabilities stood at $10000.0 in 2021, then soared by 3550.0% to $365000.0 in 2022, then tumbled by 96.16% to $14000.0 in 2023, then decreased by 14.29% to $12000.0 in 2024, then retreated by 25.0% to $9000.0 in 2025.
- Business Quant data shows TLSA's Other Non-Current Liabilities at $9000.0 in Q2 2025, $12000.0 in Q4 2024, and $8000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 9,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Jun 30, 2021 | 83,000.00 |
| Dec 31, 2020 | 81,867.96 |
| Dec 31, 2019 | 81,000.67 |